U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients with multiple risk factors for serious illness.
Posted in
#canadahealth #canadahealthy #canadalistings #canadastory #canadianhealth Health Search Canada Online Listing

